Literature DB >> 30030240

Vascular endothelial growth factor signaling in development and disease.

Sinem Karaman1, Veli-Matti Leppänen1, Kari Alitalo2.   

Abstract

Vascular endothelial growth factors (VEGFs) are best known for their involvement in orchestrating the development and maintenance of the blood and lymphatic vascular systems. VEGFs are secreted by a variety of cells and they bind to their cognate tyrosine kinase VEGF receptors (VEGFRs) in endothelial cells to elicit various downstream effects. In recent years, there has been tremendous progress in elucidating different VEGF/VEGFR signaling functions in both the blood and lymphatic vascular systems. Here, and in the accompanying poster, we present key elements of the VEGF/VEGFR pathway and highlight the classical and newly discovered functions of VEGF signaling in blood and lymphatic vessel development and pathology.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Receptor tyrosine kinase; VEGF; Vessels

Mesh:

Substances:

Year:  2018        PMID: 30030240     DOI: 10.1242/dev.151019

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  73 in total

1.  [Establishment of a rat model of dimethylbenzanthracene-induced vulvar squamous intraepithelial lesions].

Authors:  Yijin Fan; Huajun Tang; Yao Liu; Chengzhi Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.

Authors:  Hannes C A Drexler; Matthias Vockel; Christian Polaschegg; Maike Frye; Kevin Peters; Dietmar Vestweber
Journal:  Mol Cell Proteomics       Date:  2019-08-19       Impact factor: 5.911

3.  High glucose concentration produces a short-term increase in pERK1/2 and p85 proteins, having a direct angiogenetic effect by an action similar to VEGF.

Authors:  Candida Zuchegna; Ferdinando Carlo Sasso; Mario Felice Tecce; Anna Capasso; Luigi Elio Adinolfi; Antonella Romano; Silvia Bartollino; Antonio Porcellini; Ciro Costagliola
Journal:  Acta Diabetol       Date:  2020-03-04       Impact factor: 4.280

Review 4.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

5.  ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.

Authors:  Dong Li; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Christoph Seiler; Erin Pinto; Leticia S Matsuoka; Mark R Battig; Elizabeth J Bhoj; Tara L Wenger; Lifeng Tian; Nora Robinson; Tiancheng Wang; Yichuan Liu; Brant M Weinstein; Matthew Swift; Hyun Min Jung; Courtney N Kaminski; Rosetta Chiavacci; Jonathan A Perkins; Michael A Levine; Patrick M A Sleiman; Patricia J Hicks; Janet T Strausbaugh; Jean B Belasco; Yoav Dori; Hakon Hakonarson
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

6.  Effects of ginkgo diterpene lactone on brain inflammation and oxidative stress in rats with cognitive impairment of cerebral small vessel disease.

Authors:  Shan Jiang; Xianjun Ma; Yinyi Chen; Baodong Gu; Na Sun; Hui Xiao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

7.  Simultaneous fluorescence imaging of distinct nerve and blood vessel patterns in dual Thy1-YFP and Flt1-DsRed transgenic mice.

Authors:  Samuel M Santosa; Kai Guo; Michael Yamakawa; Evguenia Ivakhnitskaia; Neeraj Chawla; Tara Nguyen; Kyu-Yeon Han; Masatsugu Ema; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Angiogenesis       Date:  2020-05-05       Impact factor: 9.596

8.  A Network Pharmacology Approach to Predict the Proangiogenesis Mechanism of Huangqi-Honghua Herb Pair after Cerebral Ischemia.

Authors:  Jinyi Cao; Lu Lei; Kai Wang; Jing Sun; Yi Qiao; Jialin Duan; Chao Zhao; Jia Cui; Zhijun Feng; Jing-Wen Wang; Aidong Wen; Zhifu Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-14       Impact factor: 2.629

Review 9.  The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.

Authors:  Richard M Monaghan; Donna J Page; Pia Ostergaard; Bernard D Keavney
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

Review 10.  Identifying Novel Actionable Targets in Colon Cancer.

Authors:  Maria Grazia Cerrito; Emanuela Grassilli
Journal:  Biomedicines       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.